Gene/Protein Disease Symptom Drug Enzyme Compound
Pivot Concepts:   Target Concepts:
Query: UMLS:C0001175 (AIDS)
 120,706 document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)

A bill (H.R. 1598) to extend the patents on Claritin and a half dozen other drugs is scheduled for a congressional hearing on July 1. While the legislation does not affect AIDS drugs, activists fear the setting of a precedent when AIDS drugs go off patent in coming years. Schering, Claritin's manufacturer, is financing a huge effort to have the patent extension bill passed. Information is provided for those wanting more information about H.R. 1598.
AIDS Treat News 1999 Jun 18
PMID:Action alert: drug-patent bill could cost patients $3 billion+; hearing July 1. 1136 16